Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2025)

Bausch Health Companies' (BHC) quarterly Asset Writedowns and Impairment came in at $7.0 million in Q4 2025, down 69.57% year-on-year from $23.0 million in Q4 2024, and up 600.0% quarter-over-quarter from $1.0 million in Q3 2025.

Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2025) Analysis & Trends

Bausch Health Companies has disclosed Asset Writedowns and Impairment across 12 years of filings, most recently posting $7.0 million for Q4 2025.

  • Asset Writedowns and Impairment for Q4 2025 came in at $7.0 million, down 69.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.0 million (down 72.41% YoY), and the FY2025 annual result was $8.0 million, down 72.41% from the prior year.
  • Asset Writedowns and Impairment came in at $7.0 million for Q4 2025 at Bausch Health Companies, up from $1.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $148.0 million in Q1 2021 to a low of $1.0 million in Q3 2022.
  • The 5-year median for Asset Writedowns and Impairment is $8.0 million (2022), against an average of $22.7 million.
  • Across the five-year window, Asset Writedowns and Impairment soared 4600.0% in 2021 and sank 94.59% in 2022, its largest moves.
  • Bausch Health Companies' Asset Writedowns and Impairment stood at $21.0 million in 2021, then slumped by 95.24% to $1.0 million in 2022, then surged by 300.0% to $4.0 million in 2023, then jumped by 475.0% to $23.0 million in 2024, then tumbled by 69.57% to $7.0 million in 2025.
  • The last three Asset Writedowns and Impairment figures came in at $7.0 million (Q4 2025), $1.0 million (Q3 2025), and $23.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Bausch Health Companies 1.92 Bn 1.58 Bn 2.48 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.00 Mn
Dec 31, 2025 7.00 Mn
Sep 30, 2025 1.00 Mn
Sep 30, 2025 1.00 Mn
Dec 31, 2024 23.00 Mn
Dec 31, 2024 23.00 Mn
Jun 30, 2024 5.00 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 1.00 Mn
Mar 31, 2024 1.00 Mn
Sep 30, 2023 4.00 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 37.00 Mn
Jun 30, 2023 37.00 Mn
Mar 31, 2023 13.00 Mn
Mar 31, 2023 13.00 Mn
Sep 30, 2022 1.00 Mn
Sep 30, 2022 1.00 Mn
Jun 30, 2022 6.00 Mn
Jun 30, 2022 6.00 Mn